MedWatch

Zealand Pharma issues almost USD 40m in shares

The firm’s issuance and private placement represent 6.6% of its currently registered share capital, and will bring in an expected total of DKK 275m (USD 39.4m).

Photo: Zealand Pharma / PR

Biotech firm Zealand Pharma has announced a directed issuance of 2.89 million new shares and a private placement, corresponding to a total 6.6% of the firm’s share capital.

The price per share is DKK 95 (USD 13.6), and the firm expects gross proceeds to amount to DKK 275m (USD 39.4m), according to a notification released on Wednesday after trading closed.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs